0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Percutaneous Transluminal Angioplasty Instrument - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-36Z12489
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Percutaneous Transluminal Angioplasty Instrument Market Research Report 2022
BUY CHAPTERS

Percutaneous Transluminal Angioplasty Instrument - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-36Z12489
Report
December 2024
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Percutaneous Transluminal Angioplasty Instrument - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Percutaneous Transluminal Angioplasty Instrument - Market

Percutaneous Transluminal Angioplasty Instrument - Market

The global market for Percutaneous Transluminal Angioplasty Instrument was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Percutaneous Transluminal Angioplasty Instrument, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Percutaneous Transluminal Angioplasty Instrument by region & country, by Type, and by Application.
The Percutaneous Transluminal Angioplasty Instrument market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Percutaneous Transluminal Angioplasty Instrument.
Market Segmentation

Scope of Percutaneous Transluminal Angioplasty Instrument - Market Report

Report Metric Details
Report Name Percutaneous Transluminal Angioplasty Instrument - Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type:
  • Introducer
  • Angiographic Catheter
  • Balloon Catheter
  • Guide Wire
  • Stent
  • Others
Segment by Application
  • Below 40 Years Old
  • 40 ~ 60 Years Old
  • Above 60 Years Old
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Boston Scientific, Medtronic, Terumo Medical, Lepu Medical, MicroPort, Biosensors, B.Braun, Atrium Medical, Biotronik, Asahi Intecc, Cardinal, Integer, Cook Medical, TE Connectivity, Merit, SP Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Percutaneous Transluminal Angioplasty Instrument manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Percutaneous Transluminal Angioplasty Instrument in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Percutaneous Transluminal Angioplasty Instrument in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Percutaneous Transluminal Angioplasty Instrument - Market report?

Ans: The main players in the Percutaneous Transluminal Angioplasty Instrument - Market are Abbott, Boston Scientific, Medtronic, Terumo Medical, Lepu Medical, MicroPort, Biosensors, B.Braun, Atrium Medical, Biotronik, Asahi Intecc, Cardinal, Integer, Cook Medical, TE Connectivity, Merit, SP Medical

What are the Application segmentation covered in the Percutaneous Transluminal Angioplasty Instrument - Market report?

Ans: The Applications covered in the Percutaneous Transluminal Angioplasty Instrument - Market report are Below 40 Years Old, 40 ~ 60 Years Old, Above 60 Years Old

What are the Type segmentation covered in the Percutaneous Transluminal Angioplasty Instrument - Market report?

Ans: The Types covered in the Percutaneous Transluminal Angioplasty Instrument - Market report are Introducer, Angiographic Catheter, Balloon Catheter, Guide Wire, Stent, Others

1 Market Overview
1.1 Percutaneous Transluminal Angioplasty Instrument Product Introduction
1.2 Global Percutaneous Transluminal Angioplasty Instrument Market Size Forecast
1.3 Percutaneous Transluminal Angioplasty Instrument Market Trends & Drivers
1.3.1 Percutaneous Transluminal Angioplasty Instrument Industry Trends
1.3.2 Percutaneous Transluminal Angioplasty Instrument Market Drivers & Opportunity
1.3.3 Percutaneous Transluminal Angioplasty Instrument Market Challenges
1.3.4 Percutaneous Transluminal Angioplasty Instrument Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Percutaneous Transluminal Angioplasty Instrument Players Revenue Ranking (2023)
2.2 Global Percutaneous Transluminal Angioplasty Instrument Revenue by Company (2019-2024)
2.3 Key Companies Percutaneous Transluminal Angioplasty Instrument Manufacturing Base Distribution and Headquarters
2.4 Key Companies Percutaneous Transluminal Angioplasty Instrument Product Offered
2.5 Key Companies Time to Begin Mass Production of Percutaneous Transluminal Angioplasty Instrument
2.6 Percutaneous Transluminal Angioplasty Instrument Market Competitive Analysis
2.6.1 Percutaneous Transluminal Angioplasty Instrument Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Percutaneous Transluminal Angioplasty Instrument Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Transluminal Angioplasty Instrument as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Introducer
3.1.2 Angiographic Catheter
3.1.3 Balloon Catheter
3.1.4 Guide Wire
3.1.5 Stent
3.1.6 Others
3.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type
3.2.1 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value, by Type (2019-2030)
3.2.3 Global Percutaneous Transluminal Angioplasty Instrument Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Below 40 Years Old
4.1.2 40 ~ 60 Years Old
4.1.3 Above 60 Years Old
4.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application
4.2.1 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value, by Application (2019-2030)
4.2.3 Global Percutaneous Transluminal Angioplasty Instrument Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region
5.1.1 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region (2019-2024)
5.1.3 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region (2025-2030)
5.1.4 Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
5.2.2 North America Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
5.3.2 Europe Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
5.4.2 Asia Pacific Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
5.5.2 South America Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
5.6.2 Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Percutaneous Transluminal Angioplasty Instrument Sales Value
6.3 United States
6.3.1 United States Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
6.3.2 United States Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Percutaneous Transluminal Angioplasty Instrument Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
6.4.2 Europe Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Percutaneous Transluminal Angioplasty Instrument Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
6.5.2 China Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
6.5.3 China Percutaneous Transluminal Angioplasty Instrument Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
6.6.2 Japan Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Percutaneous Transluminal Angioplasty Instrument Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
6.7.2 South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
6.8.2 Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019-2030
6.9.2 India Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
6.9.3 India Percutaneous Transluminal Angioplasty Instrument Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.1.4 Abbott Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Recent Developments
7.2 Boston Scientific
7.2.1 Boston Scientific Profile
7.2.2 Boston Scientific Main Business
7.2.3 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.2.4 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.2.5 Boston Scientific Recent Developments
7.3 Medtronic
7.3.1 Medtronic Profile
7.3.2 Medtronic Main Business
7.3.3 Medtronic Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.3.4 Medtronic Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.3.5 Terumo Medical Recent Developments
7.4 Terumo Medical
7.4.1 Terumo Medical Profile
7.4.2 Terumo Medical Main Business
7.4.3 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.4.4 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.4.5 Terumo Medical Recent Developments
7.5 Lepu Medical
7.5.1 Lepu Medical Profile
7.5.2 Lepu Medical Main Business
7.5.3 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.5.4 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.5.5 Lepu Medical Recent Developments
7.6 MicroPort
7.6.1 MicroPort Profile
7.6.2 MicroPort Main Business
7.6.3 MicroPort Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.6.4 MicroPort Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.6.5 MicroPort Recent Developments
7.7 Biosensors
7.7.1 Biosensors Profile
7.7.2 Biosensors Main Business
7.7.3 Biosensors Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.7.4 Biosensors Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.7.5 Biosensors Recent Developments
7.8 B.Braun
7.8.1 B.Braun Profile
7.8.2 B.Braun Main Business
7.8.3 B.Braun Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.8.4 B.Braun Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.8.5 B.Braun Recent Developments
7.9 Atrium Medical
7.9.1 Atrium Medical Profile
7.9.2 Atrium Medical Main Business
7.9.3 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.9.4 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.9.5 Atrium Medical Recent Developments
7.10 Biotronik
7.10.1 Biotronik Profile
7.10.2 Biotronik Main Business
7.10.3 Biotronik Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.10.4 Biotronik Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.10.5 Biotronik Recent Developments
7.11 Asahi Intecc
7.11.1 Asahi Intecc Profile
7.11.2 Asahi Intecc Main Business
7.11.3 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.11.4 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.11.5 Asahi Intecc Recent Developments
7.12 Cardinal
7.12.1 Cardinal Profile
7.12.2 Cardinal Main Business
7.12.3 Cardinal Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.12.4 Cardinal Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.12.5 Cardinal Recent Developments
7.13 Integer
7.13.1 Integer Profile
7.13.2 Integer Main Business
7.13.3 Integer Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.13.4 Integer Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.13.5 Integer Recent Developments
7.14 Cook Medical
7.14.1 Cook Medical Profile
7.14.2 Cook Medical Main Business
7.14.3 Cook Medical Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.14.4 Cook Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.14.5 Cook Medical Recent Developments
7.15 TE Connectivity
7.15.1 TE Connectivity Profile
7.15.2 TE Connectivity Main Business
7.15.3 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.15.4 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.15.5 TE Connectivity Recent Developments
7.16 Merit
7.16.1 Merit Profile
7.16.2 Merit Main Business
7.16.3 Merit Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.16.4 Merit Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.16.5 Merit Recent Developments
7.17 SP Medical
7.17.1 SP Medical Profile
7.17.2 SP Medical Main Business
7.17.3 SP Medical Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
7.17.4 SP Medical Percutaneous Transluminal Angioplasty Instrument Revenue (US$ Million) & (2019-2024)
7.17.5 SP Medical Recent Developments
8 Industry Chain Analysis
8.1 Percutaneous Transluminal Angioplasty Instrument Industrial Chain
8.2 Percutaneous Transluminal Angioplasty Instrument Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Percutaneous Transluminal Angioplasty Instrument Sales Model
8.5.2 Sales Channel
8.5.3 Percutaneous Transluminal Angioplasty Instrument Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Percutaneous Transluminal Angioplasty Instrument Market Trends
    Table 2. Percutaneous Transluminal Angioplasty Instrument Market Drivers & Opportunity
    Table 3. Percutaneous Transluminal Angioplasty Instrument Market Challenges
    Table 4. Percutaneous Transluminal Angioplasty Instrument Market Restraints
    Table 5. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Percutaneous Transluminal Angioplasty Instrument Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Percutaneous Transluminal Angioplasty Instrument Product Type
    Table 9. Key Companies Time to Begin Mass Production of Percutaneous Transluminal Angioplasty Instrument
    Table 10. Global Percutaneous Transluminal Angioplasty Instrument Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Transluminal Angioplasty Instrument as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Percutaneous Transluminal Angioplasty Instrument Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Percutaneous Transluminal Angioplasty Instrument Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Percutaneous Transluminal Angioplasty Instrument Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Percutaneous Transluminal Angioplasty Instrument Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region (2019-2024) & (%)
    Table 27. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Percutaneous Transluminal Angioplasty Instrument Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Percutaneous Transluminal Angioplasty Instrument Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Percutaneous Transluminal Angioplasty Instrument Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Basic Information List
    Table 32. Abbott Description and Business Overview
    Table 33. Abbott Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Abbott (2019-2024)
    Table 35. Abbott Recent Developments
    Table 36. Boston Scientific Basic Information List
    Table 37. Boston Scientific Description and Business Overview
    Table 38. Boston Scientific Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Boston Scientific (2019-2024)
    Table 40. Boston Scientific Recent Developments
    Table 41. Medtronic Basic Information List
    Table 42. Medtronic Description and Business Overview
    Table 43. Medtronic Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Medtronic (2019-2024)
    Table 45. Medtronic Recent Developments
    Table 46. Terumo Medical Basic Information List
    Table 47. Terumo Medical Description and Business Overview
    Table 48. Terumo Medical Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Terumo Medical (2019-2024)
    Table 50. Terumo Medical Recent Developments
    Table 51. Lepu Medical Basic Information List
    Table 52. Lepu Medical Description and Business Overview
    Table 53. Lepu Medical Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Lepu Medical (2019-2024)
    Table 55. Lepu Medical Recent Developments
    Table 56. MicroPort Basic Information List
    Table 57. MicroPort Description and Business Overview
    Table 58. MicroPort Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of MicroPort (2019-2024)
    Table 60. MicroPort Recent Developments
    Table 61. Biosensors Basic Information List
    Table 62. Biosensors Description and Business Overview
    Table 63. Biosensors Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Biosensors (2019-2024)
    Table 65. Biosensors Recent Developments
    Table 66. B.Braun Basic Information List
    Table 67. B.Braun Description and Business Overview
    Table 68. B.Braun Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of B.Braun (2019-2024)
    Table 70. B.Braun Recent Developments
    Table 71. Atrium Medical Basic Information List
    Table 72. Atrium Medical Description and Business Overview
    Table 73. Atrium Medical Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Atrium Medical (2019-2024)
    Table 75. Atrium Medical Recent Developments
    Table 76. Biotronik Basic Information List
    Table 77. Biotronik Description and Business Overview
    Table 78. Biotronik Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Biotronik (2019-2024)
    Table 80. Biotronik Recent Developments
    Table 81. Asahi Intecc Basic Information List
    Table 82. Asahi Intecc Description and Business Overview
    Table 83. Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Asahi Intecc (2019-2024)
    Table 85. Asahi Intecc Recent Developments
    Table 86. Cardinal Basic Information List
    Table 87. Cardinal Description and Business Overview
    Table 88. Cardinal Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Cardinal (2019-2024)
    Table 90. Cardinal Recent Developments
    Table 91. Integer Basic Information List
    Table 92. Integer Description and Business Overview
    Table 93. Integer Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Integer (2019-2024)
    Table 95. Integer Recent Developments
    Table 96. Cook Medical Basic Information List
    Table 97. Cook Medical Description and Business Overview
    Table 98. Cook Medical Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Cook Medical (2019-2024)
    Table 100. Cook Medical Recent Developments
    Table 101. TE Connectivity Basic Information List
    Table 102. TE Connectivity Description and Business Overview
    Table 103. TE Connectivity Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of TE Connectivity (2019-2024)
    Table 105. TE Connectivity Recent Developments
    Table 106. Merit Basic Information List
    Table 107. Merit Description and Business Overview
    Table 108. Merit Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of Merit (2019-2024)
    Table 110. Merit Recent Developments
    Table 111. SP Medical Basic Information List
    Table 112. SP Medical Description and Business Overview
    Table 113. SP Medical Percutaneous Transluminal Angioplasty Instrument Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Percutaneous Transluminal Angioplasty Instrument Business of SP Medical (2019-2024)
    Table 115. SP Medical Recent Developments
    Table 116. Key Raw Materials Lists
    Table 117. Raw Materials Key Suppliers Lists
    Table 118. Percutaneous Transluminal Angioplasty Instrument Downstream Customers
    Table 119. Percutaneous Transluminal Angioplasty Instrument Distributors List
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
    Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Percutaneous Transluminal Angioplasty Instrument Product Picture
    Figure 2. Global Percutaneous Transluminal Angioplasty Instrument Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Percutaneous Transluminal Angioplasty Instrument Sales Value (2019-2030) & (US$ Million)
    Figure 4. Percutaneous Transluminal Angioplasty Instrument Report Years Considered
    Figure 5. Global Percutaneous Transluminal Angioplasty Instrument Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Percutaneous Transluminal Angioplasty Instrument Revenue in 2023
    Figure 7. Percutaneous Transluminal Angioplasty Instrument Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Introducer Picture
    Figure 9. Angiographic Catheter Picture
    Figure 10. Balloon Catheter Picture
    Figure 11. Guide Wire Picture
    Figure 12. Stent Picture
    Figure 13. Others Picture
    Figure 14. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Below 40 Years Old
    Figure 17. Product Picture of 40 ~ 60 Years Old
    Figure 18. Product Picture of Above 60 Years Old
    Figure 19. Global Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Percutaneous Transluminal Angioplasty Instrument Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Percutaneous Transluminal Angioplasty Instrument Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Percutaneous Transluminal Angioplasty Instrument Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Percutaneous Transluminal Angioplasty Instrument Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Percutaneous Transluminal Angioplasty Instrument Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Percutaneous Transluminal Angioplasty Instrument Sales Value (%), (2019-2030)
    Figure 32. United States Percutaneous Transluminal Angioplasty Instrument Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Percutaneous Transluminal Angioplasty Instrument Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Percutaneous Transluminal Angioplasty Instrument Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Percutaneous Transluminal Angioplasty Instrument Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Percutaneous Transluminal Angioplasty Instrument Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Percutaneous Transluminal Angioplasty Instrument Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Percutaneous Transluminal Angioplasty Instrument Sales Value by Application (%), 2023 VS 2030
    Figure 53. Percutaneous Transluminal Angioplasty Instrument Industrial Chain
    Figure 54. Percutaneous Transluminal Angioplasty Instrument Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS